disease

Climate Change Is Bringing Legionnaire’s Disease to a Town Near You

'Neural pruning' drives smell loss in early, silent stages of Alzheimer's | Scientists uncover the mechanism behind the loss of smell – which can be one of the first indicators of Alzheimer's disease

Magnetized pen detects Parkinson's disease in its earliest stages | The prototype pen is able to detect subtle Parkinson's-related tremors via writing exercises such as drawing continuous spirals

Nanoflowers: The new frontier in healing brain cells & treating disease

SpaceX just launched disease-causing bacteria to the International Space Station

How Not to Study a Disease (2023)

Super-resolution microscopes reveal new details of cells and disease

Researchers have discovered that newborns have high levels of the tau protein, which is elevated in older people with Alzheimer’s disease, but that it causes them no harm | The discovery opens the door to developing new ways of treating or preventing the neurodegenerative condition.

Breakthrough brain sugar discovery turns the tables on Alzheimer's disease | Sugar stores in the brain were previously thought to be unimportant

Doctors find Parkinson's markers by looking inside ears | Analysis of ear wax to detect Parkinson's Disease would be a cheap, non-invasive way to detect the condition in its early stages

Pancreatic cancer vaccine eradicates trace of disease in early trials

FDA Clears First Blood Test To Help Diagnose Alzheimer's Disease

The FDA clears the first blood test for diagnosing Alzheimer's disease

AI Helps Unravel a Cause of Alzheimer's Disease and Identify a Therapeutic Candidate

AI helps unravel a cause of Alzheimer’s and identify a therapeutic candidate

Empty Calories of AI: A Cure for Loneliness Worse Than the Disease?

Phase I/II trial of iPS-cell-derived dopaminergic cells for Parkinson's disease

AI models miss disease in Black and female patients

Parkinson's treatment closer as problematic protein imaged for first time | Known as PINK1, the protein has been linked to the disease for decades but its structure and how to switch it back on have remained elusive – until now.

Alzheimer's biomarkers now visible up to a decade ahead of symptoms